Bill > SB2402

This bill expands the scope of practice for pharmacists in North Dakota by allowing them to independently prescribe certain drugs and devices, and to substitute therapeutically equivalent drugs under specific conditions. It amends existing laws to clarify that pharmacists can order, perform, and interpret laboratory tests as authorized by chapter 43-15 and related administrative rules, repealing a previous section that specifically listed approved laboratory tests. The bill also introduces definitions for "patient-pharmacist relationship" and clarifies the "practice of pharmacy" to include ordering and performing laboratory tests. Pharmacists can now prescribe drugs for conditions like lice, cold sores, motion sickness, and hypoglycemia, as well as certain devices like inhalers and nebulizers. They can also prescribe drugs for influenza, strep throat, and COVID-19 if the patient tests positive, and for specific preventative measures like post-exposure prophylaxis for HIV and Lyme disease. Furthermore, pharmacists can prescribe certain drugs in emergency situations and for travel medicine. For therapeutic substitution, pharmacists can substitute a drug for a therapeutically equivalent one, with exceptions for certain drug classes and if the prescriber or the board prohibits it, provided they discuss the substitution with the patient, inform them of their right to refuse, and notify the prescriber within 24 hours. The bill also adds a provision to section 43-48-03 regarding pharmacists being duly and currently licensed to practice pharmacy.

Government Affairs

Legislative Management (Joint)

https://ndlegis.gov/assembly/69-2025/special/bill-overview/bo2402.html